NCT03854539View on ClinicalTrials.gov

Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2018

Primary Completion Date

June 8, 2020

Study Completion Date

June 8, 2020

Conditions
No Condition Salivary Alpha Amylase
Interventions
OTHER

Transdermal Vagus Nerve Stimulation

intermittent transdermal stimulation of the aurical vagus

Trial Locations (1)

72801

Arkansas Tech University, Russellville

All Listed Sponsors
lead

Arkansas Tech University

OTHER

NCT03854539 - Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation | Biotech Hunter | Biotech Hunter